Semaglutide for Alcohol Use Disorder

Clinical trial NCT05520775 · COMPLETED

Trial details

NCT number: NCT05520775
Sponsor: University of North Carolina, Chapel Hill
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alcohol Use Disorder Cigarette Smoking

Start date: 2022-09-02
Primary completion: 2024-04-12
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.